BVF PARTNERS L P/IL reported 3 transactions at CRESCENT BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
+657.31K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+556.62K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+56.08K
Price / share
—
Trade value
—
% of position
Net shares
+1.27M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2025 | J · J | +657.31K | — | — | 1319.7% | 49.81K | 707.12K |
| Common Stock Direct | 6/13/2025 | J · J | +556.62K | — | — | 1499.4% | 37.12K | 593.74K |
| Common Stock Direct | 6/13/2025 | J · J | +56.08K | — | — | 889.6% | 6.30K | 62.38K |
| Total | +1.27M | $0.00 | ||||||
Pre-Funded Warrants to Purchase Common Stock
Common Stock
304.10K shares
Shares
+304.10K
Strike price
Held after
304.10K
Exercisable
—
Pre-Funded Warrants to Purchase Common Stock
Common Stock
257.51K shares
Shares
+257.51K
Strike price
Held after
257.51K
Exercisable
—
Pre-Funded Warrants to Purchase Common Stock
Common Stock
25.94K shares
Shares
+25.94K
Strike price
Held after
25.94K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-Funded Warrants to Purchase Common Stock Direct | Common Stock304.10K shares | 6/13/2025 | J · J | +304.10K | — | 304.10K | |
| Pre-Funded Warrants to Purchase Common Stock Direct | Common Stock257.51K shares | 6/13/2025 | J · J | +257.51K | — | 257.51K | |
| Pre-Funded Warrants to Purchase Common Stock Direct | Common Stock25.94K shares | 6/13/2025 | J · J | +25.94K | — | 25.94K |